Bausch Health Companies Inc. (BHC) FY2026 YTD Q2 P&L / Income Statement

Bausch Health Companies Inc. (BHC) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

5,376,000,000 US dollars

Cost of revenue (calculated)

1,510,000,000 US dollars

Gross profit (calculated)

3,866,000,000 US dollars

Operating expenses (calculated)

4,076,000,000 US dollars

Operating income (loss)

negative 210,000,000 US dollars

Other income (expense), net (calculated)

negative 796,000,000 US dollars

Income (loss) before income taxes

negative 1,006,000,000 US dollars

Provision for income taxes

165,000,000 US dollars

Net income (loss)

negative 1,171,000,000 US dollars

Salix

1,397,000,000 US dollars

International

590,000,000 US dollars

Solta Medical

347,000,000 US dollars

Diversified

404,000,000 US dollars

Bausch + Lomb

2,638,000,000 US dollars

Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues

1,510,000,000 US dollars

Selling, general and administrative

1,768,000,000 US dollars

Research and development

336,000,000 US dollars

Amortization of intangible assets

466,000,000 US dollars

Goodwill impairments

1,426,000,000 US dollars

Restructuring, integration and separation costs

22,000,000 US dollars

Other expense (income), net

58,000,000 US dollars

Salix costs (calculated)

324,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

International costs (calculated)

412,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Solta Medical costs (calculated)

181,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Diversified costs (calculated)

150,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Bausch + Lomb costs (calculated)

2,026,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Reconciling items (calculated)

2,493,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Bausch Health Companies Inc.: −$1.17 B; to noncontrolling interests: −$6.00 M.